Immunotherapy

• Design and Development of a Device (Sifilotto^®) for Tumour Tracking in Cervical Cancer Patients Undergoing Robotic Arm LINAC Stereotactic Body Radiation Therapy Boost: Background to the STARBACS Study
• Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma
• Cancer Stem Cell Characterization in Olfactory Neuroblastoma Tissue
• TRIM22 promotes glioblastoma development by ubiquitinating Bcl-2
• Patient-Derived Glioblastoma Explants Empower Rapid and Personalized Drug Assessment: Harnessing the Potential of 3D Perfusion Bioreactors in Glioblastoma Drug Discovery
• Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges
• Ectopic expression of GDF15 in cancer-associated fibroblasts enhances melanoma immunosuppression via the GFRAL/RET cascade
• Machine learning-driven SLC prognostic signature for glioma: predicting survival and immunotherapy response

Immunotherapy is a type of medical treatment that harnesses the body's own immune system to combat diseases, particularly cancer and certain autoimmune disorders. The immune system is a complex network of cells, tissues, and molecules that work together to defend the body against harmful invaders like bacteria, viruses, and abnormal cells.

Combination immunotherapy.

CAR-T cell therapy

Monoclonal Antibody

Immune Checkpoint Inhibitor and combinations

see Cancer Immunotherapy.

Glioblastoma Immunotherapy.

The immune reaction during ischemia opens new doors for advanced targeted therapeutics. Nowadays stem cell therapy has shown better results in stroke-prone individuals. Few monoclonal antibodies like natalizumab have shown a great impact on pre-clinical and clinical stroke trial studies ¹⁾.